Your browser doesn't support javascript.
loading
Long-lasting neutralizing antibody responses in SARS-CoV-2 seropositive individuals are robustly boosted by immunization with the CoronaVac and BNT162b2 vaccines.
Muena, Nicolás A; García-Salum, Tamara; Pardo-Roa, Catalina; Serrano, Eileen F; Levican, Jorge; Avendaño, María José; Almonacid, Leonardo I; Valenzuela, Gonzalo; Poblete, Estefany; Strohmeier, Shirin; Salinas, Erick; Haslwanter, Denise; Dieterle, Maria Eugenia; Jangra, Rohit K; Chandran, Kartik; González, Claudia; Riquelme, Arnoldo; Krammer, Florian; Tischler, Nicole D; Medina, Rafael A.
Affiliation
  • Muena NA; Laboratorio de Virología Molecular, Fundación Ciencia & Vida, Av. Zañartu 1482, Santiago, Chile.
  • García-Salum T; Department of Pediatric Infectious Diseases and Immunology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Pardo-Roa C; Advanced Interdisciplinary Rehabilitation Register (AIRR) - COVID-19 Working Group, Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Serrano EF; Department of Pediatric Infectious Diseases and Immunology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Levican J; Advanced Interdisciplinary Rehabilitation Register (AIRR) - COVID-19 Working Group, Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Avendaño MJ; Department of Pediatric Infectious Diseases and Immunology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Almonacid LI; PhD Program in Biological Sciences, Mention in Molecular Genetics and Microbiology, Faculty of Biological Science, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Valenzuela G; Department of Pediatric Infectious Diseases and Immunology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Poblete E; Advanced Interdisciplinary Rehabilitation Register (AIRR) - COVID-19 Working Group, Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Strohmeier S; Department of Pediatric Infectious Diseases and Immunology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Salinas E; PhD Program in Biological Sciences, Mention in Molecular Genetics and Microbiology, Faculty of Biological Science, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Haslwanter D; Department of Pediatric Infectious Diseases and Immunology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Dieterle ME; Department of Pediatric Infectious Diseases and Immunology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Jangra RK; Department of Pediatric Infectious Diseases and Immunology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Chandran K; Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • González C; Department of Pediatric Infectious Diseases and Immunology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Riquelme A; Advanced Interdisciplinary Rehabilitation Register (AIRR) - COVID-19 Working Group, Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Krammer F; Department of Microbiology and Immunology, Albert Einstein College of Medicine, New York, NY, USA.
  • Tischler ND; Department of Microbiology and Immunology, Albert Einstein College of Medicine, New York, NY, USA.
  • Medina RA; Department of Microbiology and Immunology, Albert Einstein College of Medicine, New York, NY, USA.
medRxiv ; 2021 May 18.
Article in En | MEDLINE | ID: mdl-34031662

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: MedRxiv Year: 2021 Type: Article Affiliation country: Chile

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: MedRxiv Year: 2021 Type: Article Affiliation country: Chile